Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fondazione Italiana Linfomi - ETS
The study does not require any intervention on the patient, but it involves the simple collection of data that are already present in the medical record. Since this is a retrospective study, it will not require further analysis or diagnostic investigations than those already made.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with initial diagnosis of follicular lymphoma since 2001
Histological confirmation of follicular lymphoma, grade I, II, III according to WHO 2008 classification, at the time of initial diagnosis
Systemic first-line treatment with immuno-chemotherapy
PET availability at the time of response after first-line treatment (optional)
Clinical and radiological evidence of FL relapse or progression
Histological confirmation of relapse (strongly recommended)
PET availability of at the time of relapse/progression and images available for central assessment
Availability of clinical, laboratory and therapeutic treatment data at the time of initial diagnosis and relapse/progression
Follow up of at least 12 months after relapse/progression
